BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30948370)

  • 1. Biphenotypic plasma cell myeloma.
    Kurt H; Ferreira KA
    Blood; 2019 Apr; 133(14):1611. PubMed ID: 30948370
    [No Abstract]   [Full Text] [Related]  

  • 2. Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains.
    Jiwani S; Bornhost J; Alapat D
    Int J Clin Exp Pathol; 2015; 8(7):8536-44. PubMed ID: 26339430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular and intracellular crystal deposition in plasma cell myeloma.
    He R; Dao LN
    Blood; 2014 Feb; 123(6):807. PubMed ID: 24660231
    [No Abstract]   [Full Text] [Related]  

  • 4. An approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/lambda ratios of CD38-gated CD138(+) cells.
    Nakayama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Takayama A; Nishiwaki U; Masuda Y; Ikemoto T; Tanaka H; Nishimura Y; Tsuji M; Hanafusa T
    Diagn Pathol; 2012 Sep; 7():131. PubMed ID: 23021410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An approach for plasma cell myeloma diagnosis by two-color flow cytometry based on kappa/lambda ratios of CD38-gated plasma cells.
    Nakayama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Takayama A; Nishiwaki U; Masuda Y; Ikemoto T; Tanaka H; Nishimura Y; Tsuji M; Hanafusa T
    Int J Immunopathol Pharmacol; 2013; 26(2):479-83. PubMed ID: 23755763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma.
    Warnnissorn AN; Treetipsatit J; Limvorapitak W
    Hematology; 2020 Dec; 25(1):292-298. PubMed ID: 32772824
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-secretory or low-secretory myeloma with intracellular kappa chains. Report of six cases and review of the literature.
    Turesson I; Grubb A
    Acta Med Scand; 1978; 204(6):445-51. PubMed ID: 104550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistological diagnosis of plasma cell myeloma based on cytoplasmic kappa/lambda ratio of CD138-positive plasma cells.
    Nakayama-Ichiyama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Takayama A; Nishiwaki U; Masuda Y; Nishimura Y; Tsuji M; Hanafusa T
    Leuk Lymphoma; 2012 Nov; 53(11):2205-9. PubMed ID: 22506669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleural effusion in a patient with multiple myeloma.
    Oudart JB; Maquart FX; Semouma O; Lauer M; Arthuis-Demoulin P; Ramont L
    Clin Chem; 2012 Apr; 58(4):672-4. PubMed ID: 22461512
    [No Abstract]   [Full Text] [Related]  

  • 10. [The proportion of kappa and lambda light chains among monotypic IgG and IgA].
    Nikolić V; Dovezenski N; Milosević-Jovcić N
    Srp Arh Celok Lek; 1986; 114(11-12):991-9. PubMed ID: 3109038
    [No Abstract]   [Full Text] [Related]  

  • 11. Simultaneous occurrence of clinical manifestations of myeloma and Waldenström's macroglobulinemia with monoclonal IgG Lambda and IgM Kappa in a single patient.
    Fine JM; Gorin NC; Gendre JP; Petitpierre JC; Labro-Bryskier MT; Lambin P
    Acta Med Scand; 1981; 209(3):229-34. PubMed ID: 6784449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic significance of kappa/lambda and lambda/kappa ratio in paraproteinemias.
    Tichý M; Hrncír Z
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1982; 25(3-4):313-8. PubMed ID: 6820852
    [No Abstract]   [Full Text] [Related]  

  • 13. [Monoclonal plasmocytic myeloma with 2 paraproteins, IgG kappa and IgG lambdal].
    Villiamey J; Bouvet JP; Di Menza C; Boccara M
    Nouv Presse Med; 1974 Dec; 3(45):2707-11. PubMed ID: 4142506
    [No Abstract]   [Full Text] [Related]  

  • 14. [Light chain myeloma or the pitfalls of myeloma diagnosis].
    Zufferey P; Pugin P; Regamey C
    Schweiz Med Wochenschr; 1989 Jun; 119(22):791-5. PubMed ID: 2503870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coexistence of a myeloma and a granulocytic leukemia in the absence of any treatment. Study of 4 cases].
    Tursz T; Flandrin G; Brouet JC; Seligmann M
    Nouv Rev Fr Hematol; 1974; 14(6):693-704. PubMed ID: 4377020
    [No Abstract]   [Full Text] [Related]  

  • 16. [Laboratory contribution to the diagnosis of micromolecular myeloma. Description of 5 cases].
    Derelli E; Donati E; Martinazzoli F; Pasini C; Savio E
    Quad Sclavo Diagn; 1984 Jun; 20(2):171-80. PubMed ID: 6441961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel type of clonally involved cytoplasmic immunoglobulin-negative cells in multiple myeloma: flow cytometric study.
    Shimazaki C; Gotoh H; Oku N; Ashihara E; Inaba T; Murakami S; Ura Y; Nakagawa M; Fujita N
    Acta Haematol; 1992; 88(2-3):86-91. PubMed ID: 1466204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory analysis of cases of light chain disease.
    Kraj M; Rostkowska J; Pogłód R
    Acta Med Pol; 1987; 28(1-4):73-98. PubMed ID: 3146896
    [No Abstract]   [Full Text] [Related]  

  • 19. Light chain isotype associated suppression of surface immunoglobulin expression on peripheral blood lymphocytes in myeloma during plateau phase.
    Wearne A; Joshua DE; Kronenberg H
    Br J Haematol; 1984 Nov; 58(3):483-9. PubMed ID: 6437432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum-free light chain analysis: works in progress.
    Merlini G
    Clin Chem Lab Med; 2009; 47(9):1021-2. PubMed ID: 19728842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.